Search
- Jun 7
Hopewell Therapeutics’ CEO on the company’s $25M raise and next-gen LNPs
Lou Brenner discusses his company’s raise today and explains how Hopewell is designing LNPs to go beyond the liver.
top of page
Search
Follow BiotechTV
Also look for unique social pages for BiotechTV U.
Popular
#1. Pfizer’s CEO on Q2 earnings.
​
#2. Moderna CEO Stéphane Bancel on Moderna’s business at its R&D Day in New York
​
#3. UPenn’s Bruce Levine discusses the progress of CAR-T
​
#4. Learning about gene writing at Tessera Therapeutics
#5. Visiting Bayer’s Research and Innovation Center in Kendall Square
bottom of page